<DOC>
	<DOC>NCT00634348</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy and safety of ziprasidone and aripiprazole in hospitalized patients with schizophrenia or schizoaffective disorder</brief_summary>
	<brief_title>A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Hospitalized patients with schizophrenia or schizoaffective disorder At least a 6th grade reading level Males or females, between 18 and 70 years of age at the time of consent Subjects must have been hospitalized for no more than 14 consecutive days immediately prior to screening Psychiatric disorder other than schizophrenia or schizoaffective disorder History of arrhythmia, heart attack, or heart failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>